HLA-B27

(Redirected from Ddx:HLA-B27)
Jump to navigation Jump to search

WikiDoc Resources for HLA-B27

Articles

Most recent articles on HLA-B27

Most cited articles on HLA-B27

Review articles on HLA-B27

Articles on HLA-B27 in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on HLA-B27

Images of HLA-B27

Photos of HLA-B27

Podcasts & MP3s on HLA-B27

Videos on HLA-B27

Evidence Based Medicine

Cochrane Collaboration on HLA-B27

Bandolier on HLA-B27

TRIP on HLA-B27

Clinical Trials

Ongoing Trials on HLA-B27 at Clinical Trials.gov

Trial results on HLA-B27

Clinical Trials on HLA-B27 at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on HLA-B27

NICE Guidance on HLA-B27

NHS PRODIGY Guidance

FDA on HLA-B27

CDC on HLA-B27

Books

Books on HLA-B27

News

HLA-B27 in the news

Be alerted to news on HLA-B27

News trends on HLA-B27

Commentary

Blogs on HLA-B27

Definitions

Definitions of HLA-B27

Patient Resources / Community

Patient resources on HLA-B27

Discussion groups on HLA-B27

Patient Handouts on HLA-B27

Directions to Hospitals Treating HLA-B27

Risk calculators and risk factors for HLA-B27

Healthcare Provider Resources

Symptoms of HLA-B27

Causes & Risk Factors for HLA-B27

Diagnostic studies for HLA-B27

Treatment of HLA-B27

Continuing Medical Education (CME)

CME Programs on HLA-B27

International

HLA-B27 en Espanol

HLA-B27 en Francais

Business

HLA-B27 in the Marketplace

Patents on HLA-B27

Experimental / Informatics

List of terms related to HLA-B27

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Human Leukocyte Antigen B*27 (subtypes B*2701-2724) is a class I surface antigen encoded by the B locus in the major histocompatibility complex (MHC) on chromosome 6 and presents microbial antigens to T-cells. HLA-B27 strongly associated with a certain set of autoimmune diseases referred to as the "seronegative spondyloarthropathies". In the general population, about 8% Caucasian, 4% African, 2-9% Chinese, and 0.1-0.5% Japanese have the HLA-B27 antigen. In Northern Scandinavia (Lapland), 24% of people are HLA-B27 positive while 1.8% have ankylosing spondylitis (AS).

Mystery

The relationship between HLA-B27 and many diseases has not yet been fully elucidated. Though it is associated with a wide range of pathology, it does not appear to be the sole mediator in development of disease. For example, while nearly all people with ankylosing spondylitis (AS) are HLA-B27 positive, only a fraction of people with HLA-B27 ever develop AS. This raises two important questions: why don't all HLA-B27 positive people develop AS, and why do some (although rarely) people who are HLA-B27 negative develop it? The literature is inconclusive, though several theories have been suggested and research continues.

Associated pathology

In addition to its connection with AS, HLA-B27 is implicated in Reiter's syndrome, certain eye disorders such as acute anterior uveitis and iritis, psoriatic arthritis and Crohn's disease. Reiter's syndrome then again, is statistically associated with AS.

See also

External links

  • HLA-B27 Syndromes at eMedicine by A. Luisa Di Lorenzo, MBBCh
  • Bowness P (2002). "HLA B27 in health and disease: a double-edged sword?". Rheumatology (Oxford). 41 (8): 857–68. PMID 12154202.
  • Online Mendelian Inheritance in Man (OMIM) 142830
  • HLA-B27 at the US National Library of Medicine Medical Subject Headings (MeSH)

Template:HLAB

de:HLA-B27


Template:WikiDoc Sources